Roybal Lab
@roybal_lab
Followers
502
Following
0
Statuses
11
Updates from the Roybal Lab at UCSF. We are focused on engineering the next generation of immune cell therapeutics.
San Francisco
Joined March 2021
0
15
0
RT @dbgoodman: Why test #celltherapies one-by-one when you can use #SynBio to design, learn, and iterate on thousands in parallel? Our team…
0
17
0
RT @KoleRoybal: Excited to share our paper @CellCellPress Ray Liu and Iowis Zhu led the development of clinically…
0
50
0
Congratulations to @CamilliaAzimi for her Graduate Women in Science Fellowship @GWISci awarded to just seven outstanding women scientists during the 2020-2021 funding cycle. Exceptional work Camillia, you continue to impress! #womeninSTEM
#womeninscience
0
6
13
RT @dbgoodman: Excited to share new work w/ co-lead @CamilliaAzimi, @MarsonLab @kickassscience1 @roybal_lab: using a method we call 'CAR Po…
0
74
0
Congratulations to Roybal lab Post Doc Ray Liu and MD/PhD student Iowis Zhu for their engineering of SyNthetic Intramembrane Proteolysis Receptors (SNIPRs). Preprint is up now!
1/4 Excited to share our new preprint from the @roybal_lab & @MoKhalilLab-Raymond Liu and Iowis Zhu led the development of NextGen synNotch receptors. SynNotch is one ‘species’ in a larger ‘genus’ of SyNthetic Intramembrane Proteolysis Receptors (SNIPRs)
0
0
6
RT @ScienceMagazine: Two teams have created a new generation of highly specific CAR T cells, which safely cleared solid tumors in mice with…
0
47
0
Congratulations to @roybal_lab members Axel and Julie for their publication in Science Translational Medicine! This paper investigates novel synNotch CAR circuits that enhance tumor recognition through combinatorial antigen signatures in mesothelioma and ovarian cancer.
0
1
5
RT @UCSFCancer: Today #AACR21: @KoleRoybal on-demand session "Towards Engineering of Neoantigen-Specific T-Cell Therapies" followed on 4/13…
0
3
0